Biotech Stock News (RXII) (CLVS) (AZN)

Rxi Pharmaceuticals (NASDAQ:RXII) On May 3, 2016 Rxi Pharmaceuticals announced that it had entered into a license agreement with Thera NeuroPharma for the treatment of ALS or Lou Gherig’s Disease. ALS stands for amyotrophic lateral sclerosis, and is a debilitating disease where nerves in the muscles breakdown reducing/eliminating movement. Rxi entered the agreement with this … Read more